Signatures for drug repositioning - PubMed (original) (raw)
Comment
. 2011 Sep 16;12(10):668.
doi: 10.1038/nrg3076.
- PMID: 21921924
- DOI: 10.1038/nrg3076
Comment
Signatures for drug repositioning
Charlotte Harrison. Nat Rev Genet. 2011.
No abstract available
Comment on
- Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.
Dudley JT, Sirota M, Shenoy M, Pai RK, Roedder S, Chiang AP, Morgan AA, Sarwal MM, Pasricha PJ, Butte AJ. Dudley JT, et al. Sci Transl Med. 2011 Aug 17;3(96):96ra76. doi: 10.1126/scitranslmed.3002648. Sci Transl Med. 2011. PMID: 21849664 Free PMC article. - Discovery and preclinical validation of drug indications using compendia of public gene expression data.
Sirota M, Dudley JT, Kim J, Chiang AP, Morgan AA, Sweet-Cordero A, Sage J, Butte AJ. Sirota M, et al. Sci Transl Med. 2011 Aug 17;3(96):96ra77. doi: 10.1126/scitranslmed.3001318. Sci Transl Med. 2011. PMID: 21849665 Free PMC article.
Similar articles
- A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data.
Wang F, Lei X, Wu FX. Wang F, et al. Curr Med Chem. 2020;27(32):5340-5350. doi: 10.2174/0929867325666181101115801. Curr Med Chem. 2020. PMID: 30381060 Review. - DrugSig: A resource for computational drug repositioning utilizing gene expression signatures.
Wu H, Huang J, Zhong Y, Huang Q. Wu H, et al. PLoS One. 2017 May 31;12(5):e0177743. doi: 10.1371/journal.pone.0177743. eCollection 2017. PLoS One. 2017. PMID: 28562632 Free PMC article. - PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA, Domingo-Fernández D, Hoyt CT, Hofmann-Apitius M. Emon MA, et al. BMC Bioinformatics. 2020 Jun 5;21(1):231. doi: 10.1186/s12859-020-03568-5. BMC Bioinformatics. 2020. PMID: 32503412 Free PMC article. - Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Jang D, Lee S, Lee J, Kim K, Lee D. Jang D, et al. J Biomed Inform. 2016 Feb;59:248-57. doi: 10.1016/j.jbi.2015.12.003. Epub 2015 Dec 17. J Biomed Inform. 2016. PMID: 26707452 - Drug repositioning: a brief overview.
Jourdan JP, Bureau R, Rochais C, Dallemagne P. Jourdan JP, et al. J Pharm Pharmacol. 2020 Sep;72(9):1145-1151. doi: 10.1111/jphp.13273. Epub 2020 Apr 17. J Pharm Pharmacol. 2020. PMID: 32301512 Free PMC article. Review.
Cited by
- VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies.
Hu Z, Chang YC, Wang Y, Huang CL, Liu Y, Tian F, Granger B, Delisi C. Hu Z, et al. Nucleic Acids Res. 2013 Jul;41(Web Server issue):W225-31. doi: 10.1093/nar/gkt401. Epub 2013 May 28. Nucleic Acids Res. 2013. PMID: 23716640 Free PMC article. - A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide.
Fan-Minogue H, Bodapati S, Solow-Cordero D, Fan A, Paulmurugan R, Massoud TF, Felsher DW, Gambhir SS. Fan-Minogue H, et al. Mol Cancer Ther. 2013 Sep;12(9):1896-905. doi: 10.1158/1535-7163.MCT-12-1243. Epub 2013 Jul 3. Mol Cancer Ther. 2013. PMID: 23825064 Free PMC article. - Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain.
Wang X, Grace PM, Pham MN, Cheng K, Strand KA, Smith C, Li J, Watkins LR, Yin H. Wang X, et al. FASEB J. 2013 Jul;27(7):2713-22. doi: 10.1096/fj.12-222992. Epub 2013 Apr 8. FASEB J. 2013. PMID: 23568774 Free PMC article. - Transcriptional data: a new gateway to drug repositioning?
Iorio F, Rittman T, Ge H, Menden M, Saez-Rodriguez J. Iorio F, et al. Drug Discov Today. 2013 Apr;18(7-8):350-7. doi: 10.1016/j.drudis.2012.07.014. Epub 2012 Aug 7. Drug Discov Today. 2013. PMID: 22897878 Free PMC article. - Using VisANT to Analyze Networks.
Hu Z. Hu Z. Curr Protoc Bioinformatics. 2014;45(88):8.8.1-39. doi: 10.1002/0471250953.bi0808s45. Curr Protoc Bioinformatics. 2014. PMID: 25422679 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources